A controlled comparison of two fully supervised once-weekly regimens in the treatment of newly diagnosed pulmonary tuberculosis.
D000293:Adolescent; D000328:Adult; D000636:Aminosalicylic Acids / Q000009:adverse effects; D002986:Clinical Trials as Topic; D004342:Drug Hypersensitivity; D004352:Drug Resistance, Microbial; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D007538:Isoniazid / Q000008:administration & dosage* / Q000097:blood / Q000627:therapeutic use; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D009169:Mycobacterium tuberculosis / Q000302:isolation & purification; D011736:Pyridoxine / Q000009:adverse effects / Q000627:therapeutic use; D011859:Radiography; D013183:Sputum / Q000382:microbiology; D013307:Streptomycin / Q000008:administration & dosage* / Q000097:blood / Q000627:therapeutic use; D013997:Time Factors; D014397:Tuberculosis, Pulmonary / Q000000981:diagnostic imaging / Q000188:drug therapy*
D000636:Aminosalicylic Acids; D011736:Pyridoxine; D007538:Isoniazid; D013307:Streptomycin